TAL
SAGE

TIG Advisors LLC’s Sage Therapeutics SAGE Stock Holding History

TIG Advisors LLC’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-83,200
Closed -$759K – 99
2025
Q2 		$759K Sell
83,200
-2,649,071
-97% -$19.5M 0.04% 49
2025
Q1 		$21.7M Buy
+2,732,271
New +$20M 1.36% 23

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

TIG Advisors LLC's SAGE Position: Q3 2025 in Review

TIG Advisors LLC sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 83,200 shares — an estimated $759K sold.

TIG Advisors LLC first reported a position in SAGE in Q1 2025 and held it in 2 quarters. The position peaked at $21.7M in Q1 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • TIG Advisors LLC reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • TIG Advisors LLC sold 83,200 Sage Therapeutics shares in Q3 2025, an estimated $759K.
  • TIG Advisors LLC first reported a position in Sage Therapeutics in Q1 2025 and held it in 2 quarters.
  • TIG Advisors LLC's Sage Therapeutics position peaked at $21.7M in Q1 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on TIG Advisors LLC's 13F filing for Q3 2025, filed 14 Nov 2025.